Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1986-5-2
|
pubmed:abstractText |
We have examined the recovery of natural killer (NK) cell function in seven recipients of MHC matched T cell depleted bone marrow allografts. NK cell activity against the erythroblastoid line K562 recovers 2-3 weeks after transplantation. Recipients also show a high level of killing of the T cell target HSB2 and of EBV transformed lymphoblastoid cell lines (B-LCL). This activity peaks at 4-6 weeks and declines towards normal by 12-14 weeks after transplantation. Although killing of HSB2 and B-LCL is usually the property of activated NK cells, few of these patients had any obvious 'trigger' of such activation: none had CMV infection, there were no episodes of graft rejection, and only two patients had mild and transient grade I graft versus host disease (GvHD). We conclude that T cell depletion does not affect the reconstitution of NK cell function and that NK cell activation occurs after T depleted bone marrow transplantation even in the absence of clinically detectable GvHD, graft rejection or CMV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
413-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3513817-Adolescent,
pubmed-meshheading:3513817-Adult,
pubmed-meshheading:3513817-Bone Marrow Transplantation,
pubmed-meshheading:3513817-Cytotoxicity Tests, Immunologic,
pubmed-meshheading:3513817-Humans,
pubmed-meshheading:3513817-Killer Cells, Natural,
pubmed-meshheading:3513817-Leukemia,
pubmed-meshheading:3513817-Middle Aged,
pubmed-meshheading:3513817-Postoperative Period,
pubmed-meshheading:3513817-T-Lymphocytes
|
pubmed:year |
1986
|
pubmed:articleTitle |
Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|